scholarly journals Dietary Supplement‐Use and Physical Activity among Long‐Term Cancer Survivors

2007 ◽  
Vol 21 (5) ◽  
Author(s):  
Paige Elizabeth Miller ◽  
Terryl J Hartman ◽  
Joseph J Vasey ◽  
Pamela F Short
2008 ◽  
Vol 2 (3) ◽  
pp. 138-148 ◽  
Author(s):  
Paige Miller ◽  
Wendy Demark-Wahnefried ◽  
Denise Clutter Snyder ◽  
Richard Sloane ◽  
Miriam C. Morey ◽  
...  

2019 ◽  
Author(s):  
Mengxi Du ◽  
Jeffrey B. Blumberg ◽  
Zhilei Shan ◽  
Gail Rogers ◽  
Fan Chen ◽  
...  

2020 ◽  
Vol 39 (1) ◽  
pp. 234-241 ◽  
Author(s):  
Janna L. Koole ◽  
Martijn J.L. Bours ◽  
José J.L. Breedveld-Peters ◽  
Eline H. van Roekel ◽  
Stéphanie O. Breukink ◽  
...  

2015 ◽  
Vol 114 (2) ◽  
pp. 286-296 ◽  
Author(s):  
Martijn J. Bours ◽  
Sandra Beijer ◽  
Renate M. Winkels ◽  
Fränzel J. van Duijnhoven ◽  
Floortje Mols ◽  
...  

In the present study, we aimed to describe dietary changes made post-diagnosis and current dietary supplement use by survivors of colorectal cancer (CRC), and explore the underlying motives for these lifestyle habits. Cross-sectional analyses were performed for 1458 stage I–IV CRC survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry, diagnosed between 2000 and 2009. Lifestyle, sociodemographic and clinical information was collected. Prevalence of and motivations for dietary changes and supplement use were assessed. Associations between lifestyle, sociodemographic and clinical variables were analysed by multivariable logistic regression. CRC survivors (57 % male) were on average 70 (sd 9) years of age and diagnosed 7 (sd 3) years ago. Dietary changes post-diagnosis were reported by 36 % of the survivors and current supplement use by 32 %. Motivations for dietary changes were mostly cancer-related (44 % reported ‘prevention of cancer recurrence’ as the main reason), while motivations for supplement use were less frequently related to the cancer experience (38 % reported ‘to improve health and prevent disease in general’ as the main reason). Dietary changes were significantly associated with dietary supplement use (OR 1·5, 95 % CI 1·1, 2·1). Survivors who had received dietary advice, were non-smokers, under 65 years of age, and had no stoma were more likely to have changed their diet. Survivors who were female, had multiple co-morbidities, and no overweight or obesity were more likely to use supplements. In conclusion, many CRC survivors alter their diet post-diagnosis and use dietary supplements, in part for different reasons. Insights into motivations behind these lifestyle habits and characteristics of CRC survivors adopting these habits can improve the tailoring of lifestyle counselling strategies.


Nutrients ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 3730
Author(s):  
Maura Harrigan ◽  
Courtney McGowan ◽  
Annette Hood ◽  
Leah M. Ferrucci ◽  
ThaiHien Nguyen ◽  
...  

The use of dietary supplements is common in the general population and even more prevalent among cancer survivors. The World Cancer Research Fund/American Institute for Cancer Research specifies that dietary supplements should not be used for cancer prevention. Several dietary supplements have potential pharmacokinetic and pharmacodynamic interactions that may change their clinical efficacy or potentiate adverse effects of the adjuvant endocrine therapy prescribed for breast cancer treatment. This analysis examined the prevalence of self-reported dietary supplement use and the potential interactions with tamoxifen and aromatase inhibitors (AIs) among breast cancer survivors enrolled in three randomized controlled trials of lifestyle interventions conducted between 2010 and 2017. The potential interactions with tamoxifen and AIs were identified using the Natural Medicine Database. Among 475 breast cancer survivors (2.9 (mean) or 2.5 (standard deviation) years from diagnosis), 393 (83%) reported using dietary supplements. A total of 108 different types of dietary supplements were reported and 36 potential adverse interactions with tamoxifen or AIs were identified. Among the 353 women taking tamoxifen or AIs, 38% were taking dietary supplements with a potential risk of interactions. We observed a high prevalence of dietary supplement use among breast cancer survivors and the potential for adverse interactions between the prescribed endocrine therapy and dietary supplements was common.


2009 ◽  
Vol 36 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Paige E. Miller ◽  
Joseph J. Vasey ◽  
Pamela F. Short ◽  
Terryl J. Hartman

2008 ◽  
Vol 26 (4) ◽  
pp. 665-673 ◽  
Author(s):  
Christine M. Velicer ◽  
Cornelia M. Ulrich

Vitamin and mineral supplement use is thought to be common among the 10 million adults in the United States who have been diagnosed with cancer; however, well-conducted studies of this topic are sparse. Moreover, the biologic effects of supplement use among cancer survivors are not well established and not necessarily beneficial. We present a systematic summary of studies published between 1999 and 2006, 32 in total, addressing vitamin and mineral supplement use among US adult cancer patients and survivors. Supplement use is widespread among cancer patients and longer-term survivors. In studies combining different cancer sites, 64% to 81% of survivors reported using any vitamin or mineral supplements and 26% to 77% reported using any multivitamins. In contrast, approximately 50% of US adults use dietary supplements and 33% use multivitamin/multimineral supplements. Between 14% and 32% of survivors initiate supplement use after diagnosis, and use differs by cancer site. Breast cancer survivors reported the highest use, whereas prostate cancer survivors reported the least. Higher level of education and female sex emerged as factors most consistently associated with supplement use. Up to 68% of physicians are unaware of supplement use among their cancer patients. These results highlight the need for further studies of the association between dietary supplement use and cancer treatment toxicity, recurrence, survival, and quality of life to support evidence-based clinical guidelines for dietary supplement use among cancer patients and longer-term survivors.


2017 ◽  
Author(s):  
Farrukh M. Koraishy ◽  
Gilbert W. Moeckel ◽  
David S. Geller

Sign in / Sign up

Export Citation Format

Share Document